醫療財團法人辜公亮基金會和信治癌中心醫院

內分泌腫瘤

團隊成員

吳佳興資深主治醫師Jia-Shing Wu

放射腫瘤科

所屬團隊

乳癌肺癌及食道癌大腸直腸癌頭頸癌及鼻咽癌泌尿系癌血液淋巴腫瘤內分泌腫瘤

醫師簡介

個人接受過完整的腫瘤內科及放射腫瘤科訓練，並不斷更新癌症診療全方位的知識。希望藉由個人專業及團隊合作，追求細節完美、精確，帶給每個病人量身定作，最適合的治療。

現職

和信治癌中心醫院放射腫瘤科資深主治醫師 2019~ 迄今

專長

腫瘤放射治療、立體定位放射線治療、頭頸腫瘤、大腸直腸癌、乳癌、肺癌、食道癌、鼻咽癌、淋巴癌、泌尿道腫瘤

政治大學經營管理碩士學程碩士 2021-2024
臺大醫學院醫學系學士 1990.09~1997.06

和信治癌中心醫院放射腫瘤科主治醫師 2008.07~迄今
和信治癌中心醫院放射腫瘤科住院醫師 2004.07~2008.05
臺大醫院腫瘤內科專研醫師 2002.07~2004.06
臺大醫院內科住院醫師 1999.07~2002.06

台北市醫師公會會員
台灣內科醫學會會員
中華民國放射腫瘤學會會員
中華民國癌症醫學會會員

PUBLICATION

Wu JS, Jen CW, Chen HH, Cheng SH. Stereotactic body radiotherapy and checkpoint inhibitor for locally recurrent unresectable nasopharyngeal carcinoma. BMJ Case Rep. 2021;14:e240806.
Jen C-W, Tsai Y-C, Wu J-S et al. Prognostic classification for patients with nasopharyngeal carcinoma based on the American Joint Committee on Cancer staging system T and N categories. Therapeutic Radiology and Oncology. 2020;4:2-2.
Wu JS, Tsai YC, Jian JJ, Chen HH, Horng CF, Cheng SH. Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone. Head Neck. 2018;40:2070-2077.
Liu Z, Goldstein AM, Hsu WL, Wu JS, et al. Evaluation of Rare and Common Variants from Suspected Familial or Sporadic Nasopharyngeal Carcinoma (NPC) Susceptibility Genes in Sporadic NPC. Cancer Epidemiol Biomarkers Prev. 2019;28:1682-1686.
Wu JS, Horng DF, Tsai YC, Chung YL, Jian JJ, Cheng SH. The Comparison of Nodal Stage Determined by Magnetic Resonance Imaging and Clinical Palpation for Nasopharyngeal Carcinoma Patients with Bulky Lymph Node Metastasis. Therapeutic Radiology and Oncology. 2008;15:189-199.
Lin YL, Chung CY, Chang CS, Wu JS et al. Prognostic factors in extrapulmonary small cell carcinomas. A large retrospective study. Oncology. 2007;72:181-187.
Lin YC, Tsai CH, Wu JS et al. Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast--a review of 42 primary and secondary cases in Taiwanese patients. Leuk. Lymphoma. 2009;50:918-924.

Conference Abstract

Wu JS, Cheng SH, Jian JJ, Chen H, Chu N, Chan K, et al. Long-term Outcome of a Risk-adapted Protocol for Nasopharyngeal Carcinoma. Int J Radiat Oncol [Internet]. Elsevier; 2012 Nov 21;84(3):S208–9
Wu JS, Tsai YC, Intensity-modulated radiotherapy for inoperable/unresectable recurrent differentiated thyroid cancer; 2023, European Society of Therapeutic Radiation Oncology